37,000+ hCGers Join hcgChica's Email Tribe how-to's | interviews | pep talks Yup, I want this!
Am J Sports Med 33(4):561567 Ferretti A, Puddu G, Mariani PP, Neri M (1984) Jumpers knee: an epidemiological study of volleyball players
One type of peptide can be designed based on this mechanism
Excipients and adjuvant peptides induce a mild immune activation: CD8 + T-cell responses were reported in 4 of 11 patients [84]
Desired Dose (mg) Supports 30+ peptides including GLP-1s (Tirzepatide, Retatrutide, Semaglutide), BPC-157, Semax, Selank, MOTS-c, Tesamorelin, NAD+, and peptide blends (BPC-157 + TB-500, GLOW, KLOW), with BAC water guidance to minimize injection site irritation
Monitoring schedule Healthcare providers who specialize in GLP-1 therapy typically recommend this monitoring cadence: Baseline: Full B12 panel before starting semaglutide 3 months: Repeat serum B12 and MMA 6 months: Full panel reassessment Annually: Once stable, annual monitoring is usually sufficient For high-risk patients (metformin users, vegans, those over 60, post-bariatric surgery), the 3-month check is particularly important
